IRWD vs LFCR

Ironwood Pharmaceuticals, Inc. vs Lifecore Biomedical, Inc. — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — IRWD scores higher on quality with 7.7/10 vs LFCR's 4.8/10. IRWD trades at $3.28 while LFCR trades at $5.45. Both analyzed daily using SEC EDGAR data across 13 institutional models.

IRWD

Drug Manufacturers - Specialty & Generic
Ironwood Pharmaceuticals, Inc.
Quality
7.7
out of 10
Value Trap
39
LOW
Price
$3.28
Last close
Models
11/13
Active
VS

LFCR

Drug Manufacturers - Specialty & Generic
Lifecore Biomedical, Inc.
Quality
4.8
out of 10
Value Trap
20
SAFE
Price
$5.45
Last close
Models
7/13
Active
IRWD
Earnings Power Value sees +70.1% upside
Limited to 2/13 visible models
LFCR
PWERM sees +13.6% upside
Quality 4.8/10 — below average

IRWD vs LFCR — Fair Value Comparison

IRWD
$0$2$4$7 Price$3.28 Earnings …$5.58 (+70.1%) EROIC Spr…$4.81 (+46.8%)
LFCR
$0$2$5$7 Price$5.45 PWERM$6.19 (+13.6%) First Chi…$0.61 (-86.0%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType IRWD Fair ValueIRWD Upside LFCR Fair ValueLFCR Upside
Earnings Power Value Intrinsic $5.58 +70.1%
EROIC Spread Intrinsic $4.81 +46.8% $1.16 -78.0%
First Chicago Scenario $4.16 +26.9% $0.61 -86.0%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $4.92 +50.0% $6.19 +13.6%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%

IRWD vs LFCR — Which Stock Is More Undervalued in 2026?

IRWD scores higher with a 7.7/10 quality rating vs LFCR's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do IRWD and LFCR Valuations Compare?

IRWD currently trades at $3.28 while LFCR trades at $5.45. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: IRWD vs LFCR

IRWD earns a Quality of Company score of 7.7/10 compared to LFCR's 4.8/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: IRWD vs LFCR

IRWD carries a LOW value trap risk (39/100) while LFCR shows SAFE risk (20/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Drug Manufacturers - Specialty & Generic

Both IRWD and LFCR operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare IRWD vs LFCR differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

See all Drug Manufacturers - Specialty & Generic stocks →